End-of-day quote
Trinidad and Tobago S.E.
18:00:00 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
18.05
TTD
|
-.--%
|
|
-2.43%
|
-4.65%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,197
|
5,023
|
4,849
|
6,961
|
6,262
|
4,392
|
Enterprise Value (EV)
1 |
4,227
|
5,154
|
4,509
|
6,794
|
6,057
|
4,804
|
P/E ratio
|
7.86
x
|
7.27
x
|
6.26
x
|
8.9
x
|
5.69
x
|
6.31
x
|
Yield
|
3.92%
|
3.46%
|
-
|
2.33%
|
2.67%
|
3.96%
|
Capitalization / Revenue
|
0.75
x
|
0.81
x
|
0.82
x
|
1.05
x
|
0.93
x
|
0.67
x
|
EV / Revenue
|
0.75
x
|
0.83
x
|
0.76
x
|
1.03
x
|
0.9
x
|
0.73
x
|
EV / EBITDA
|
4.74
x
|
4.93
x
|
3.68
x
|
6.1
x
|
4.2
x
|
4.49
x
|
EV / FCF
|
-680
x
|
6.1
x
|
7.62
x
|
7.14
x
|
7.06
x
|
7.17
x
|
FCF Yield
|
-0.15%
|
16.4%
|
13.1%
|
14%
|
14.2%
|
13.9%
|
Price to Book
|
1.24
x
|
1.27
x
|
1.04
x
|
1.4
x
|
1.13
x
|
1.14
x
|
Nbr of stocks (in thousands)
|
231,900
|
232,021
|
232,021
|
232,021
|
232,021
|
232,021
|
Reference price
2 |
18.10
|
21.65
|
20.90
|
30.00
|
26.99
|
18.93
|
Announcement Date
|
19-03-27
|
20-03-23
|
21-03-25
|
22-03-24
|
23-03-15
|
24-04-02
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,623
|
6,219
|
5,928
|
6,622
|
6,766
|
6,605
|
EBITDA
1 |
891.2
|
1,046
|
1,226
|
1,113
|
1,443
|
1,071
|
EBIT
1 |
821.5
|
972.1
|
1,152
|
1,029
|
1,350
|
993.6
|
Operating Margin
|
14.61%
|
15.63%
|
19.44%
|
15.54%
|
19.95%
|
15.04%
|
Earnings before Tax (EBT)
1 |
699.8
|
846
|
1,024
|
1,001
|
1,248
|
922.4
|
Net income
1 |
533.9
|
692.3
|
774.5
|
782.3
|
1,100
|
695.8
|
Net margin
|
9.49%
|
11.13%
|
13.06%
|
11.81%
|
16.26%
|
10.54%
|
EPS
2 |
2.304
|
2.980
|
3.338
|
3.372
|
4.743
|
2.999
|
Free Cash Flow
1 |
-6.213
|
845.5
|
591.5
|
951.5
|
857.6
|
669.7
|
FCF margin
|
-0.11%
|
13.6%
|
9.98%
|
14.37%
|
12.68%
|
10.14%
|
FCF Conversion (EBITDA)
|
-
|
80.83%
|
48.26%
|
85.49%
|
59.45%
|
62.56%
|
FCF Conversion (Net income)
|
-
|
122.13%
|
76.37%
|
121.63%
|
77.94%
|
96.25%
|
Dividend per Share
2 |
0.7100
|
0.7500
|
-
|
0.7000
|
0.7200
|
0.7500
|
Announcement Date
|
19-03-27
|
20-03-23
|
21-03-25
|
22-03-24
|
23-03-15
|
24-04-02
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
29.2
|
131
|
-
|
-
|
-
|
412
|
Net Cash position
1 |
-
|
-
|
340
|
167
|
205
|
-
|
Leverage (Debt/EBITDA)
|
0.0327
x
|
0.1249
x
|
-
|
-
|
-
|
0.3846
x
|
Free Cash Flow
1 |
-6.21
|
845
|
591
|
952
|
858
|
670
|
ROE (net income / shareholders' equity)
|
15.9%
|
18.8%
|
18.1%
|
16.3%
|
20.9%
|
20.6%
|
ROA (Net income/ Total Assets)
|
1.86%
|
2.09%
|
2.28%
|
1.9%
|
2.43%
|
1.81%
|
Assets
1 |
28,700
|
33,098
|
33,926
|
41,119
|
45,265
|
38,401
|
Book Value Per Share
2 |
14.70
|
17.00
|
20.10
|
21.40
|
24.00
|
16.60
|
Cash Flow per Share
2 |
9.910
|
10.80
|
16.00
|
16.30
|
15.40
|
12.60
|
Capex
1 |
75.6
|
142
|
52.6
|
57.8
|
63.7
|
48.4
|
Capex / Sales
|
1.34%
|
2.28%
|
0.89%
|
0.87%
|
0.94%
|
0.73%
|
Announcement Date
|
19-03-27
|
20-03-23
|
21-03-25
|
22-03-24
|
23-03-15
|
24-04-02
|
|
1st Jan change
|
Capi.
|
---|
| -4.65% | 615M | | +10.00% | 76.32B | | +7.49% | 50.69B | | +1.39% | 48.13B | | +9.67% | 42.08B | | +6.53% | 39.7B | | +19.86% | 38.01B | | +2.28% | 29.79B | | -7.16% | 27.63B | | -20.99% | 24.06B |
Other Life & Health Insurance
|